User profiles for Dušek Petr

Petr Dušek

Department of Neurology and Center of Clinical Neuroscience, Charles University, 1st …
Verified email at vfn.cz
Cited by 5480

[HTML][HTML] Trial of deferiprone in Parkinson's disease

…, N Pavese, E Růžička, P Dušek… - … England Journal of …, 2022 - Mass Medical Soc
Background Iron content is increased in the substantia nigra of persons with Parkinson’s
disease and may contribute to the pathophysiology of the disorder. Early research suggests that …

Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder

…, NJ Diederich, K Doppler, P Dušek… - The Lancet …, 2021 - thelancet.com
Patients with isolated rapid-eye-movement sleep behaviour disorder (RBD) are commonly
regarded as being in the early stages of a progressive neurodegenerative disease involving α…

Progression of clinical markers in prodromal Parkinson's disease and dementia with Lewy bodies: a multicentre study

S Joza, MT Hu, KY Jung, D Kunz, A Stefani, P Dušek… - Brain, 2023 - academic.oup.com
The neurodegenerative synucleinopathies, including Parkinson’s disease and dementia
with Lewy bodies, are characterized by a typically lengthy prodromal period of progressive …

Speech biomarkers in rapid eye movement sleep behavior disorder and Parkinson disease

…, J Montplaisir, JF Gagnon, P Dušek… - Annals of …, 2021 - Wiley Online Library
Objective This multilanguage study used simple speech recording and high‐end pattern
analysis to provide sensitive and reliable noninvasive biomarkers of prodromal versus manifest …

Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension …

…, C Küpper, C Neuhofer, B Kálmán, P Dušek… - The Lancet …, 2019 - thelancet.com
Background Pantothenate kinase-associated neurodegeneration (PKAN) is a rare genetic
disorder characterised by progressive generalised dystonia and brain iron accumulation. We …

Smartphone allows capture of speech abnormalities associated with high risk of developing Parkinson's disease

…, T Tykalová, M Novotný, P Dušek… - IEEE transactions on …, 2018 - ieeexplore.ieee.org
Although smartphone technology provides new opportunities for the recording of speech
samples in everyday life, its ability to capture prodromal speech impairment in persons with a …

Pathogenesis of Wilson disease

IF Scheiber, R Brůha, P Dušek - Handbook of clinical neurology, 2017 - Elsevier
… Author links open overlay panel Ivo Florin Scheiber 1 , Radan Brůha 2 , Petr Dušek 3 … et al.,
2013); however, the clinical consequences of these findings are unclear (Dusek et al., 2015). …

Automated speech analysis in early untreated Parkinson's disease: Relation to gender and dopaminergic transporter imaging

…, D Zogala, E Růžička, P Dušek - European journal of …, 2022 - Wiley Online Library
Background The mechanisms underlying speech abnormalities in Parkinson's disease (PD)
remain poorly understood, with most of the available evidence based on male patients. This …

[HTML][HTML] The subthalamic microlesion story in Parkinson's disease: electrode insertion-related motor improvement with relative cortico-subcortical hypoactivation in …

…, D Urgošík, T Sieger, Š Holiga, F Růžička, P Dušek… - PLoS …, 2012 - journals.plos.org
Electrode implantation into the subthalamic nucleus for deep brain stimulation in Parkinson's
disease (PD) is associated with a temporary motor improvement occurring prior to …

Deep brain stimulation of the subthalamic nucleus affects resting EEG and visual evoked potentials in Parkinson's disease

…, M Volfová, O Nováková, J Roth, P Dušek… - Clinical …, 2006 - Elsevier
OBJECTIVE: We studied changes of the EEG spectral power induced by deep brain stimulation
(DBS) of the subthalamic nucleus (STN) in patients with Parkinson's disease (PD). Also …